Intraosseous infusion devices provide rapid vascular access during emergency conditions when intravenous access cannot be established. These devices are used to administer medication, fluids or blood products directly into the marrow of bone. They are commonly used in emergency medical settings and pre-hospital environments like ambulances to treat trauma patients with a fractured bone or internal bleeding. Key advantages include faster administration compared to conventional IV cannulation, can be performed with minimal training and specialization, and has higher success rates than central venous access in critical situations.
The Global intraosseous infusion devices market is driven by rising prevalence of medical emergencies, road accidents and trauma cases globally along with lack of timely intravenous access in remote or rural areas with limited resources.
The global intraosseous infusion devices market is estimated to be valued at US$ 1111.7 Mn in 2024 and is expected to exhibit a CAGR of 5.4% over the forecast period 2024 To 2031.
Key Takeaways
Key players: Key players operating in the intraosseous infusion devices are PerSys Medical, Aero Healthcare AU Pty Ltd, Teleflex Incorporated, PAVmed Inc., BIOPSYBELL S.R.L., Becton Dickinson Company, Cook Group, SAM Medical, Argon Medical Devices, Inc., Cardinal Health, Inc.
PerSys Medical is a leading manufacturer of intraosseous infusion devices with their EZ-IO product portfolio consisting of battery-powered and manual intraosseous devices. Teleflex Incorporated provides the VIDIAN intraosseous needle system for adult patients.
Intraosseous Infusion Devices Market Growth for emergency medical services in pre-hospital settings and rural areas is driving the intraosseous infusion devices market. According to a study, around 60-70% of trauma deaths occur prior to reaching a hospital, emphasizing the need for intraosseous access during transport.
Technological advancements: Major players are focusing on innovations like battery-powered devices that reduce the need for manual insertion force and angle stability mechanisms to simplify placement procedure in tough conditions. Some innovations include visual indicators of placement and automated infusion activation controls.
Market Trends
Increased usage in pediatrics and neonatal populations: Recent clinical research has validated the safe use of intraosseous catheters, especially for resuscitation of critically ill newborns and children. This is expected to increase adoption rates.
Rising focus on trauma and disaster management preparedness: Many government organizations and NGOs involved in mass casualty and disaster response are incorporating training and procurement of intraosseous devices in their preparedness protocols to address critical hemorrhage and shock cases.
Market Opportunities
Untapped demand in developing nations: Most of the trauma mortality continues to occur in low and middle-income countries that lack sufficient emergency medical infrastructure and access to care. This represents a major untapped market potential.
Adoption in alternative clinical settings: Increasing research exploring the efficacy of intraosseous access in non-emergency surgeries like cesarean sections, orthopedic procedures and vascular access could drive new growth opportunities in hospitals as well.
Impact of COVID-19 on Intraosseous Infusion Devices Market
The COVID-19 pandemic has significantly impacted the growth of the intraosseous infusion devices market. During the initial phases of the pandemic, most elective surgeries and non-emergency procedures were postponed to avoid unnecessary exposure and focus medical resources towards treating COVID-19 patients. This led to a decline in the demand for intraosseous infusion devices in 2020. However, with the rising number of critical COVID-19 cases, the intraosseous route of administration gained prominence as it allowed for rapid vascular access in emergency settings. This boosted the adoption of intraosseous infusion devices for administering fluids and life-saving drugs to critically ill coronavirus patients. With the pandemic expected to continue affecting healthcare systems, manufacturers are focusing on ramping up production capacities of intraosseous infusion devices to meet the growing demand. They are also conducting extensive R&D to develop easy-to-use devices suitable for emergency care and field operations during public health crises. Governments and hospitals worldwide are procuring large inventories of intraosseous devices to strengthen pandemic preparedness. The long-term outlook of the intraosseous infusion devices market remains positive due to the crucial role played by these devices in trauma and emergency care even post the pandemic.
Geographical Regions with High Concentration of Intraosseous Infusion Devices Market
North America represents the most concentrated region for the intraosseous infusion devices market in terms of value. This can be attributed to factors such as the growing prevalence of chronic medical conditions increasing the need for emergency vascular access, presence of advanced healthcare infrastructure and emergency medical services industry, favorable reimbursement policies, and high adoption of novel medical technologies among healthcare professionals. The United States accounts for the major share of the North American intraosseous infusion devices market. Europe is another lucrative regional market driven by the rising geriatric population, increasing trauma cases, and availability of reimbursements for emergency medical procedures in several countries.
Fastest Growing Regional Market for Intraosseous Infusion Devices
The Asia Pacific market is slated to grow at the fastest pace during the forecast period attributed to expanding healthcare spending, rapidly developing healthcare systems across emerging economies, and rising incidence of accidents and injuries due to rapid urbanization and industrialization in the region. Furthermore, growing medical tourism industry has prompted hospitals in Asia to equip themselves with advanced life-saving technologies. This is presenting lucrative growth opportunities for intraosseous infusion devices manufacturers to establish operations locally. Countries such as China and India with their large population bases are identified to be the demand hotspots in the Asia Pacific intraosseous infusion devices market.
Get more insights on Intraosseous Infusion Devices Market
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
コメント